Condition
Peritoneal Diseases
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02973750Completed
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
NCT05185791UnknownPrimary
ERAS® Guidelines Validation of CRS With or Without HIPEC
NCT04125160Completed
Glycaemic Markers in Persons With Type 2 Diabetes on Peritoneal Dialysis
NCT03150992Not ApplicableUnknown
EDMONd - Elemental Diet in Bowel Obstruction
NCT00369096Phase 2CompletedPrimary
Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)
Showing all 5 trials